Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.

[1]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[2]  O. Yanuka,et al.  Involvement of Myc targets in c-myc and N-myc induced human tumors , 1998, Oncogene.

[3]  J Downward,et al.  Ras signalling and apoptosis. , 1998, Current opinion in genetics & development.

[4]  R. Poulsom,et al.  A robust method for isotopic riboprobe in situ hybridisation to localise mRNAs in routine pathology specimens. , 1998, European journal of histochemistry : EJH.

[5]  V. D’Agati,et al.  C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.

[6]  F M Watt,et al.  c-Myc promotes differentiation of human epidermal stem cells. , 1997, Genes & development.

[7]  Quinn Ag.  Ultraviolet radiation and skin carcinogenesis. , 1997 .

[8]  T G O'Brien,et al.  Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin. , 1997, Cancer research.

[9]  Asim Khwaja,et al.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.

[10]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[11]  D. Hanahan,et al.  Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. , 1997, Cancer research.

[12]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[13]  R. Schwartz,et al.  Premalignant keratinocytic neoplasms. , 1996, Journal of the American Academy of Dermatology.

[14]  D. Hanahan,et al.  Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. , 1995, Oncogene.

[15]  G. Prendergast,et al.  c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. , 1995, Oncogene.

[16]  T. McDonnell,et al.  Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. , 1995, Oncogene.

[17]  G. Evan,et al.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. , 1995, Nucleic acids research.

[18]  J. Gordon,et al.  In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death , 1995, The Journal of cell biology.

[19]  N. Schreiber-Agus,et al.  Contrasting roles for c‐Myc and L‐Myc in the regulation of cellular growth and differentiation in vivo. , 1995, The EMBO journal.

[20]  J. Cleveland,et al.  The role of ornithine decarboxylase in c-Myc-induced apoptosis. , 1995, Current topics in microbiology and immunology.

[21]  J. Rees,et al.  Genetic alterations in non-melanoma skin cancer. , 1994, The Journal of investigative dermatology.

[22]  J. Cleveland,et al.  Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis , 1994, Molecular and cellular biology.

[23]  M. Horton,et al.  Apoptosis induced by inhibition of intercellular contact , 1994, The Journal of cell biology.

[24]  L. Larsson,et al.  Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. , 1994, Oncogene.

[25]  B. Amati,et al.  Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. , 1994, Current opinion in genetics & development.

[26]  R. DePinho,et al.  Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. , 1994, Seminars in cancer biology.

[27]  R. Eisenman,et al.  A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. , 1993, Genes & development.

[28]  J. Garlick,et al.  Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Gerdes,et al.  The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins , 1993, The Journal of cell biology.

[30]  S. Yuspa,et al.  The Suprabasal Expression of α6β4 Integrin Is Associated with a High Risk for Malignant Progression in Mouse Skin Carcinogenesis , 1993 .

[31]  J L Cleveland,et al.  The ornithine decarboxylase gene is a transcriptional target of c-Myc. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Campbell,et al.  p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. , 1993, The Journal of investigative dermatology.

[33]  G. Evan,et al.  The role of c-myc in cell growth. , 1993, Current opinion in genetics & development.

[34]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[35]  E. Fuchs.  Genetic skin disorders of keratin. , 1992, The Journal of investigative dermatology.

[36]  S. Garte,et al.  Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats. , 1992, Radiation research.

[37]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[38]  C. Péchoux,et al.  c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions. , 1992, Journal of dermatological science.

[39]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[40]  E. Fuchs,et al.  Epidermal differentiation: the bare essentials , 1990, The Journal of cell biology.

[41]  W. Brown,et al.  Structure and polymorphism of human telomere-associated DNA , 1990, Cell.

[42]  T. Sun,et al.  Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis , 1990, Cell.

[43]  Suárez Hg.  Activated oncogenes in human tumors. , 1989 .

[44]  Didier Picard,et al.  Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells , 1989, Nature.

[45]  R. Palmiter,et al.  Oncogene-induced liver neoplasia in transgenic mice. , 1989, Oncogene.

[46]  M. Rieger,et al.  Identification of an orthologous mammalian cytokeratin gene. High degree of intron sequence conservation during evolution of human cytokeratin 10. , 1988, Journal of molecular biology.

[47]  E. Fuchs,et al.  Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation , 1988, The Journal of cell biology.

[48]  G. Rennie,et al.  MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.

[49]  S. Garte,et al.  Activation of c-myc and c-K-ras oncogenes in primary rat tumors induced by ionizing radiation. , 1987, Molecular and cellular biology.

[50]  J. Moore,et al.  A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. , 1987, Oncogene research.

[51]  E. Fuchs,et al.  Evidence for posttranscriptional regulation of the keratins expressed during hyperproliferation and malignant transformation in human epidermis , 1986, The Journal of cell biology.

[52]  G K Lewis,et al.  Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product , 1985, Molecular and cellular biology.

[53]  W. Idler,et al.  Structure of a gene for the human epidermal 67-kDa keratin. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[54]  T. Sun,et al.  The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies , 1983, The Journal of cell biology.

[55]  T. Sun,et al.  Immunolocalization of keratin polypeptides in human epidermis using monoclonal antibodies , 1982, The Journal of cell biology.

[56]  T. Slaga,et al.  alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[57]  F. J. Ensell,et al.  ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.

[58]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.